Physician

Sonia Mehta, MD

According to 2025 Medicare claims, Sonia Mehta, MD (NPI: 1902004401) practices ophthalmology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Bucks, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 19047-1785.

Mehta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,705 traditional Medicare patients, billed 61,277 HCPCS/CPT codes, and received $5,595,416 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 801 prescription claims across 220 beneficiaries totaling $57,252 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 14 records totaling $29,667. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,135,487 to $5,595,416. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.8M$5.6M2015 Medicare payment: $2,135,487 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $3,237,282 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $3,541,892 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,826,423 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $4,645,906 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,421,065 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,306,699 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,450,540 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,926,718 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,595,416 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,30211,214$2,135,487
20161,54316,438$3,237,282
20171,44216,490$3,541,892
20181,48614,831$2,826,423
20191,82521,721$4,645,906
20201,22815,261$3,421,065
20211,46319,793$4,306,699
20221,41717,159$3,450,540
20231,63354,758$4,926,718
20241,70561,277$5,595,416

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$41K$83K2015 Drug cost: $53,656 (USD; Tot_Drug_Cst)2016 Drug cost: $67,610 (USD; Tot_Drug_Cst)2017 Drug cost: $65,766 (USD; Tot_Drug_Cst)2018 Drug cost: $53,261 (USD; Tot_Drug_Cst)2019 Drug cost: $73,297 (USD; Tot_Drug_Cst)2020 Drug cost: $81,004 (USD; Tot_Drug_Cst)2021 Drug cost: $82,589 (USD; Tot_Drug_Cst)2022 Drug cost: $78,906 (USD; Tot_Drug_Cst)2023 Drug cost: $75,405 (USD; Tot_Drug_Cst)2024 Drug cost: $57,252 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015207826$53,656
2016196880$67,610
2017180781$65,766
2018152535$53,261
2019225851$73,297
2020199783$81,004
2021232907$82,589
2022179749$78,906
2023194750$75,405
2024220801$57,252

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye5683,009$107
92014Established patient complete exam of visual system845948$90
92012Established patient problem focused exam of visual system8002,617$71
92134Imaging of retina1,6144,631$32
92201Extended exam of the back part of the eye with retinal drawing344397$20

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate32014,830$19,632
ProlensaBromfenac Sodium19714$6,562
IlevroNepafenac13570$4,902
Ketorolac TromethamineKetorolac Tromethamine1645,816$4,433
Bromfenac SodiumBromfenac Sodium15640$3,025

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$14,043Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.3$15,624Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sonia Mehta, MD?

Tedicare shows public-source Medicare data for Sonia Mehta, MD (NPI 1902004401), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sonia Mehta, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sonia Mehta, MD?

Sonia Mehta, MD is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Sonia Mehta, MD have Open Payments data?

Sonia Mehta, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.